Work

Magnetic Resonance Imaging (MRI) Outcomes in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) Treated with Cladribine Tablets: Results from the 120-Week Phase IIIb Extension of the CLARITY Study (P2.114)

Year: 2016

Type: article

Study design: Clinical Trial

Source: Neurology

DOI: 10.1212/wnl.86.16_supplement.p2.114

Authors: Comi Giancarlo, Gavin Giovannoni, Stuart Cook, Kottil Rammohan, Per Soelberg-Soerensenn, Patrick Vermersch, Emily Martin, Fernando Dangond, Peter Rieckmann

Institutions: Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Queen Mary University of London, Blizard Institute, Rutgers, The State University of New Jersey, Ohio State University Hospital, Copenhagen University Hospital, Danish Multiple Sclerosis Center, Hôpital Roger Salengro, Université Lille Nord de France, EMD Serono, Inc. (United States)

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2563024238

FWCI: 0.909

Cites:

Cited by: 3

Related to: 10